オールトランスレチノ酸は,TNFシグナル伝達経路経由でスティーブンズ・ジョンソン症候群と有毒性表皮解体を悪化させる:ネットワーク毒性学,分子ドッキング,実験研究
Xiaoxiao Chen1, Zhibin Zhang2, Huizhong Hu1
1The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
Toxicology and applied pharmacology
|September 4, 2025
まとめ
オールトランス・レチノ酸 (ATRA) は,アポトーシスと炎症を活性化することによって,スティーブンズ・ジョンソン症候群 (SJS) と毒性表皮解剖 (TEN) を悪化させる可能性があります. この研究で,ATRAは
科学分野:
- 毒理学について
- 皮膚科
- 薬理学について
背景:
- スティーヴンズ・ジョンソン症候群 (SJS) と毒性表皮解剖 (TEN) は重度の皮膚による副作用です.
- オールトランスレチノ酸 (ATRA) は,ビタミンAの誘導体であり,SJS/TENを模倣する皮膚学的毒性を引き起こします.
- SJS/TENの病原性におけるATRAの役割を理解することは,薬物の安全性にとって極めて重要です.
研究 の 目的:
- SJSとTENの開発におけるATRAの潜在的な役割を調査する.
- ATRA誘発性皮膚毒性の基礎にある分子メカニズムを解明する.
- ATRAに関連するSJS/TENを緩和するための潜在的な治療目標の特定
主な方法:
- ネットワーク毒理学,分子ドッキング,実験的検証が採用された.
- ATRAとSJS/TENの共通の目標と経路は,バイオ情報学データベースを用いて特定されました.
- ケラチノサイト細胞系を用いたインビトロ実験では,ATRAが細胞活力,アポトーシス,およびサイトカイン発現に及ぼす影響を評価した.
主要な成果:
- ネットワーク分析により,ATRA誘発性SJS/TENに関与する主要な標的 (TNF,MAPK1,IL6) と経路 (TNF,MAPK,JAK-STATなど) が特定されました.
- 分子ドッキングにより,ATRAがこれらの標的に強く結合することが確認されました.
- ATRA治療では,ケラチノシートの生存能力が低下し,アポトーシスが増加し,炎症誘発性サイトカイン (TNF-α,IL6) と主要なタンパク質 (割れたカスパース-3,p-NF-κB,p65,COX-2) が上昇した.
結論:
- ATRAは,ケラチノシートのアポトーシスと炎症を促進することによって,SJS/ TENの病原性を悪化させる可能性があります.
- TNFシグナル伝達経路は,ATRAの毒性作用の重要な媒介者であるとみられる.
- 発見は,ATRA誘発性皮膚毒性および潜在的な治療戦略に関する洞察を提供します.
関連する概念動画
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
230
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
230
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
The Extrinsic Apoptotic Pathway
6.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
Toxic Reactions: Overview
1.2K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.2K


